Loading...
Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities
Fibrolamellar carcinoma (FLC) is a rare, therapeutically intractable liver cancer that disproportionately affects youth. Although FLC tumors exhibit a distinct gene expression profile, the chromatin regulatory landscape and the genes most critical for tumor cell survival remain unclear. Here, we use...
Na minha lista:
| Udgivet i: | Cell Rep |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7474926/ https://ncbi.nlm.nih.gov/pubmed/32294439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2020.03.073 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|